Wednesday, June 29, 2011


Oncology Jobs Seeing Benefits of New Melanoma Treatment

Those with oncology jobs at one of the nation's most successful cancer centers are using a new treatment for the deadliest form of skin cancer.

Cancer Treatment Centers of America at Southwestern Regional Medical Center in Tulsa recently began offering a new melanoma treatment that actually uses a patient's own immune system to fight cancer.

The treatment, which has been dubbed Yervoy, is the first therapy for inoperable or metastatic melanoma approved by the Food and Drug Administration in more than 10 years.

"We are pleased to offer this breakthrough treatment for one of the deadliest forms of cancer," Steve Mackin, president of CTCA and CEO of SRMC, said in a statement. "At CTCA, we realize that time is precious when you or a loved one are fighting cancer. When an innovative treatment comes along, we do our best to bring this option to our patients quickly."

Yervoy is unique because it treats a patient's immune system instead of the direct tumor. The treatment is administered in four, 90-minute infusions over a period of three months. Patients who use the treatment have a higher survival rate after one and two years.

Here are some facts about melanoma:



March 2009   April 2009   May 2009   June 2009   July 2009   August 2009   September 2009   October 2009   November 2009   December 2009   January 2010   February 2010   March 2010   April 2010   May 2010   June 2010   July 2010   August 2010   September 2010   October 2010   November 2010   December 2010   January 2011   February 2011   March 2011   April 2011   May 2011   June 2011   July 2011   August 2011   September 2011   October 2011   November 2011   May 2012   January 2013  

This page is powered by Blogger. Isn't yours?

Subscribe to Posts [Atom]